Peptide analysis

Peptide analysis is a combined analytical-chemistry panel, not one standalone test. It is used to check a sample's identity, purity, content, impurity profile, and batch documentation. The panel helps show whether the expected molecule is present, how clean the sample is, how much actual peptide mass it contains, and whether the results match the correct batch-specific Certificate of Analysis (COA).

Core Analytical Methods for Peptide Testing

• High-Performance Liquid Chromatography (HPLC): HPLC separates sample components and reports purity from the main peak area in the chromatogram.
• Mass Spectrometry (MS): MS checks identity by measuring the peptide's molecular weight.
• Amino Acid Analysis (AAA): AAA measures absolute peptide content by quantifying the amino acid building blocks.
• Nuclear Magnetic Resonance (NMR): NMR is optional and can add supplementary structural information beyond standard identity checks.

Risks in Interpreting Peptide Analysis Results

The main risk is treating purity percentage and peptide content as the same thing. HPLC purity describes how much of the detected signal comes from the target peptide, while content accounts for total powder mass, including non-peptide material such as water, salts, or counter-ions. A label that says "98% purity" may not clarify which method or measurement is being reported.

No single technique is enough on its own: HPLC can support a purity claim, but it does not confirm identity by itself. A genuine COA is only meaningful when it matches the exact batch number of the sample. Even high-purity samples can still contain biologically active impurities that may affect research outcomes.

Sources

1. HPLC Analysis and Purification of Peptides - PMC
2. Amino acid analysis for peptide quantitation using reversed-phase liquid chromatography combined with multiple reaction monitoring mass spectrometry
3. Liquid Chromatography-High Resolution Mass Spectrometry for Peptide Drug Quality Control - PMC
4. Impurity profiling of the most frequently encountered falsified polypeptide drugs on the Belgian market
5. Impurity profiling quality control testing of synthetic peptides using liquid chromatography-photodiode array-fluorescence and liquid chromatography-electrospray ionization-mass spectrometry: the obestatin case
6. Peptide Impurities in Commercial Synthetic Peptides and Their Implications for Vaccine Trial Assessment ▿
7. Analysis of Peptides and Conjugates by Amino Acid Analysis - PubMed
8. A Multicenter Study to Evaluate Harmonization of Assays for C-Terminal Telopeptides of Type I Collagen (ß-CTX): A Report from the IFCC-IOF Committee for Bone Metabolism (C-BM)
9. A microfluidic twin islets-on-chip device for on-line electrophysiological monitoring
10. Effects of prenatal perfluoroalkyl acid exposure on cord blood IGF2/H19 methylation and ponderal index: The Hokkaido Study
11. Population Pharmacokinetics of Teicoplanin in Preterm and Term Neonates: Is It Time for a New Dosing Regimen?
12. Surface Modification of Poly(dimethylsiloxane) Using Ionic Complementary Peptides to Minimize Nonspecific Protein Adsorption
13. Peptide Quality: Importance of Third-Party Validation - Verified Peptides
14. Reference Standards to Support Quality of Synthetic Peptide Therapeutics
15. HPLC vs Mass Spectrometry for Peptide Purity Testing
16. Peptide purity standards: HPLC, mass spec, and what >98% really means | Compound Review
17. How to Read a Peptide Certificate of Analysis (COA): Complete Guide
18. Peptide Certificates of Analysis: How to Read and Verify a COA (2026 Guide) | Peptidepedia